Iodide

Iodide

SCHEMBL28525835

CN1CCCC1CO.CN1CCCC1CO.I.I

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ CYP1A2 P05177 1/20 0.45
▸ CHRNB2 P17787 2/20 0.40
▸ CHRNA4 P43681 2/20 0.40
▸ CHRNA5 P30532 1/20 0.40
▸ CHRNA7 P36544 1/20 0.40
▸ CHRNB4 P30926 1/20 0.40
▸ CHRNA3 P32297 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26011209 0.98 — —
SCHEMBL30917693 0.98 — —
SCHEMBL26011205 0.98 — —
SCHEMBL178545 0.98 — —
SCHEMBL84792 0.98 — —
SCHEMBL1086946 0.98 — —
Bromide SCHEMBL7595850 0.95 POLB (0.48) POLBL3MBTL1CYP1A2CHRNB2CHRNA4
SCHEMBL7328192 0.93 POLB (0.47) POLBL3MBTL1CYP1A2CHRNB2CHRNA4
Lithium Ion SCHEMBL7328185 0.91 POLB (0.45) POLBL3MBTL1CYP1A2CHRNB2CHRNA4
SCHEMBL25262256 0.91 CYP1A2 (0.55) POLBL3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112218845-A FOXM1 inhibitor compositions and methods of use thereof 伊利诺伊大学理事会 2021-01-12 — — CN claimed
CN-112218845-A FOXM1 inhibitor compositions and methods of use thereof 伊利诺伊大学理事会 2021-01-12 — — CN disclosed
Send feedback